Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.

K K Fields; G J Elfenbein; R A Saleh; P E Zorsky; W E Janssen; J B Perkins; T G Saleh; J T Piazza; L E Kronish; M C Machak

doi:10.1002/hon.2900100111

Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.

Identifier:nobleid.org/w1/20260515/C9C92DF4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C9C92DF4.svg?ark=w1%2F20260515%2FC9C92DF4)](https://nobleid.org/work/w1/20260515/C9C92DF4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.

Identifier:nobleid.org/w1/20260515/C9C92DF4

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C9C92DF4.svg?ark=w1%2F20260515%2FC9C92DF4)](https://nobleid.org/work/w1/20260515/C9C92DF4)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work